Nextstellis is the first and only contraceptive pill containing estetrol, a native estrogen, which is produced from a plant source. It is also the first new estrogen to hit the U.S. market in more than 50 years, the company said.
Gilead Sciences' Trodelvy now can be used as a treatment in adult patients with unresectable locally advanced or metastatic TNBC who have received two or more prior systemic therapies, at least one of them for metastatic disease.
Astellas is bringing forward a new treatment option for children impacted by neurogenic detrusor overactivity, a bladder dysfunction related to neurological impairment.